BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 1504444)

  • 1. The management of diabetic proteinuria. Which antihypertensive agent?
    Cooper ME; Doyle AE
    Drugs Aging; 1992; 2(4):301-9. PubMed ID: 1504444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal protection and antihypertensive drugs: current status.
    Salvetti A; Mattei P; Sudano I
    Drugs; 1999 May; 57(5):665-93. PubMed ID: 10353294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is antihypertensive treatment the same for NIDDM and IDDM patients?
    Parving HH
    Diabetes Res Clin Pract; 1998 Apr; 39 Suppl():S43-7. PubMed ID: 9649959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal protection and angiotensin converting enzyme inhibition in microalbuminuric type I and type II diabetic patients.
    Cooper ME
    J Hypertens Suppl; 1996 Dec; 14(6):S11-4. PubMed ID: 9023709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of antihypertensive agents in prevention and treatment of diabetic nephropathy.
    Parving HH; Rossing P
    Curr Opin Nephrol Hypertens; 1994 May; 3(3):292-300. PubMed ID: 7922255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent advances in pharmacological management of hypertension in diabetic patients with nephropathy. Effects of antihypertensive drugs on kidney function and insulin sensitivity.
    Baba T; Ishizaki T
    Drugs; 1992 Apr; 43(4):464-89. PubMed ID: 1377114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Antihypertensive therapy in diabetes mellitus].
    Hess B
    Ther Umsch; 1999 Jan; 56(1):25-32. PubMed ID: 10067131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The effect of angiotensin-converting enzyme inhibitors on the progression of chronic renal failure].
    Bernadet-Monrozies P; Rostaing L; Kamar N; Durand D
    Presse Med; 2002 Nov; 31(36):1714-20. PubMed ID: 12467154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lisinopril. A review of its pharmacology and use in the management of the complications of diabetes mellitus.
    Goa KL; Haria M; Wilde MI
    Drugs; 1997 Jun; 53(6):1081-105. PubMed ID: 9179532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood pressure lowering for the prevention and treatment of diabetic kidney disease.
    Thomas MC; Atkins RC
    Drugs; 2006; 66(17):2213-34. PubMed ID: 17137404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Therapy of diabetic nephropathy].
    Stahl RA; Schoeppe W; Thaiss F
    Z Kardiol; 1993; 82 Suppl 4():45-8. PubMed ID: 8147061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ACE-inhibition and renoprotection in early diabetic nephropathy. Response to enalapril acutely and in long-term combination with conventional antihypertensive treatment.
    Pedersen MM; Christensen CK; Hansen KW; Christiansen JS; Mogensen CE
    Clin Invest Med; 1991 Dec; 14(6):642-51. PubMed ID: 1665407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal protection in diabetes--an emerging role for calcium antagonists.
    Parving HH; Tarnow L; Rossing P
    Cardiology; 1997; 88 Suppl 3():56-62. PubMed ID: 9397296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of antihypertensive therapy on progression of diabetic nephropathy.
    Luño J; Garcia de Vinuesa S; Gomez-Campdera F; Lorenzo I; Valderrábano F
    Kidney Int Suppl; 1998 Dec; 68():S112-9. PubMed ID: 9839294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal protection in hypertensive patients: selection of antihypertensive therapy.
    Wenzel RR
    Drugs; 2005; 65 Suppl 2():29-39. PubMed ID: 16398060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diabetic nephropathy: from micro- to macroalbuminuria.
    Deferrari G; Repetto M; Calvi C; Ciabattoni M; Rossi C; Robaudo C
    Nephrol Dial Transplant; 1998; 13 Suppl 8():11-5. PubMed ID: 9870419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination antihypertensive therapy in the treatment of diabetic nephropathy.
    Boner G; Cao Z; Cooper ME
    Diabetes Technol Ther; 2002; 4(3):313-21. PubMed ID: 12165170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does antihypertensive treatment prevent progression of microalbuminuria to overt proteinuria in insulin-dependent diabetic patients?
    Passa P
    J Am Soc Nephrol; 1992 Oct; 3(4 Suppl):S91-6. PubMed ID: 1457766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention and slowing down the progression of the diabetic nephropathy through antihypertensive therapy.
    Bretzel RG
    J Diabetes Complications; 1997; 11(2):112-22. PubMed ID: 9101397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationships among microalbuminuria, insulin resistance and renal-cardiac complications in insulin dependent and non insulin dependent diabetes.
    Nosadini R; Brocco E
    Exp Clin Endocrinol Diabetes; 1997; 105 Suppl 2():1-7. PubMed ID: 9288531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.